Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Human duct cells contribute to β cell compensation in insulin resistance
Ercument Dirice, … , Jiang Hu, Rohit N. Kulkarni
Ercument Dirice, … , Jiang Hu, Rohit N. Kulkarni
Published April 18, 2019
Citation Information: JCI Insight. 2019;4(8):e99576. https://doi.org/10.1172/jci.insight.99576.
View: Text | PDF
Research Article Cell biology Endocrinology

Human duct cells contribute to β cell compensation in insulin resistance

  • Text
  • PDF
Abstract

The identification of new sources of β cells is an important endeavor with therapeutic implications for diabetes. Insulin resistance, in physiological states such as pregnancy or in pathological states such as type 2 diabetes (T2D), is characterized by a compensatory increase in β cell mass. To explore the existence of a dynamic β cell reserve, we superimposed pregnancy on the liver-specific insulin receptor–KO (LIRKO) model of insulin resistance that already exhibits β cell hyperplasia and used lineage tracing to track the source of new β cells. Although both control and LIRKO mice displayed increased β cell mass in response to the relative insulin resistance of pregnancy, the further increase in mass in the latter supported a dynamic source that could be traced to pancreatic ducts. Two observations support the translational significance of these findings. First, NOD/SCID-γ LIRKO mice that became pregnant following cotransplantation of human islets and human ducts under the kidney capsule showed enhanced β cell proliferation and an increase in ductal cells positive for transcription factors expressed during β cell development. Second, we identified duct cells positive for immature β cell markers in pancreas sections from pregnant humans and in individuals with T2D. Taken together, during increased insulin demand, ductal cells contribute to the compensatory β cell pool by differentiation/neogenesis.

Authors

Ercument Dirice, Dario F. De Jesus, Sevim Kahraman, Giorgio Basile, Raymond W.S. Ng, Abdelfattah El Ouaamari, Adrian Kee Keong Teo, Shweta Bhatt, Jiang Hu, Rohit N. Kulkarni

×

Figure 6

Presence of markers of endocrine progenitors and mature β cells in duct cells and increased numbers of small islet clusters in human pregnant and T2D samples.

Options: View larger image (or click on image) Download as PowerPoint
Presence of markers of endocrine progenitors and mature β cells in duct ...
(A and C) Confocal images of sections obtained from a 22-year-old female African American in the 40th week of pregnancy (nPOD 6383) immunostained for insulin (shown in red), glucagon (shown in green), CK19 (shown in white), and DAPI (shown in blue). (A) Insulin+ ductal structures (marked by yellow arrow). (C) Small islet clusters (yellow arrow) expressing insulin and glucagon localized close to duct cells. (E) Confocal images of sections obtained from a 52-year-old female Hispanic/Latina with type 2 diabetes for 25 years (nPOD 6304) showing islets attached to CK19+ ductal cells (yellow arrow). (B, D, and F) Quantification of the percentage of (B) insulin+ duct cells (n = 3–4 patients per group, 1-way ANOVA); (D) islet clusters expressed as percentage of islets plus small islet clusters (n = 3–4 patients per group, 1-way ANOVA); and (F) total islets attached to duct cells (n = 3–4 patients per group, 1-way ANOVA). (G) A small islet cluster (yellow arrow) that appears to be budding from the ductal structures (nPOD 6383). (H) Multiple endocrine hormone–positive ductal structures (yellow arrow) (nPOD 6304). (I) Quantification of the distance of islet clusters (<10 islet cells) from the ductal structures. Between 13 and 93 islet clusters were analyzed for each pancreatic section per sample (2-tailed Student’s t test). (J–M) Human pancreas sections coimmunostained for CK19 and SOX9 (J), PDX1 (K), PAX6 (L), or MAFA (M). White arrows point to ductal cells positive for given markers. Scale bars: 25 μm. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts